š¬The BioAI Phase Shift - Matthew McPartlon & Neil Patil, Chai Discovery
This January, four big AI Ć Pharma tools deals were announced at the huge JPM Pharma conference that takes over San Francisco every year. OpenAI-backed Chai Discovery (now worth $4B) was somehow at the heart despite being all of 2 years old. The Science team is proud to bring you the first podcast with cofounder Mattā¦
We score an episode from what we can actually measure ā its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms ā the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive ā listeners rate every episode after they finish.
- No reviews yet ā be the first.
More from Latent Space: The AI Engineer Podcast
See all episodes ā
64%š¬Scaling Past Informal AI - Carina Hong, Axiom Math
š¬āWe have foundation models for language, not for physicsā ā Anima Anandkumar, Bren Professor of Computing
Simulation: the new Scaling Law ā Joon Sung Park, Simile AI
Similar episodes from other shows
More like Latent Space: The AI Engineer Podcast ā
Chai-2: The AI Model Accelerating Drug Discovery with Chai Discovery Co-Founders Jack Dent and Joshua Meier
EP 32: AI Discovers Drugs: The 2026 Clinical Trial Moment for AI in Biotech
Can AI Advance Science? DeepMind's VP of Science Weighs In
EP 53: Ai4 Podcast - Revolutionizing Healthcare: AI in Drug Discovery | Alex Zhavoronkov, Insilico Medicine
One great episode in your inbox, daily ā free.
One email a day, unsubscribe anytime. No spam, ever.